Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion.

[1]  G. Hartman,et al.  Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. , 1998, The Journal of thoracic and cardiovascular surgery.

[2]  J. Gold,et al.  Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. , 1996, The Annals of thoracic surgery.

[3]  E. Edwards,et al.  Influence of HLA matching on thoracic transplant outcomes. An analysis from the UNOS/ISHLT Thoracic Registry. , 1996, Circulation.

[4]  J. Gold,et al.  Reduction in Homologous Blood Transfusions Using a Low Prime Circuit , 1996, The Journal of ExtraCorporeal Technology.

[5]  P. Mortensen,et al.  Autotransfusion after coronary artery bypass grafting halves the number of patients needing blood transfusion. , 1996, The Annals of thoracic surgery.

[6]  R. Shemin,et al.  Role of leukocyte depletion during cardiopulmonary bypass and cardioplegic arrest. , 1995, The Annals of thoracic surgery.

[7]  R. E. Clark,et al.  A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. , 1995, Circulation.

[8]  P. Bezemer,et al.  Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits. , 1995, The Journal of thoracic and cardiovascular surgery.

[9]  C. Naylor,et al.  Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. , 1994, The Annals of thoracic surgery.

[10]  J. Klemperer,et al.  Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses. , 1994, The Annals of thoracic surgery.

[11]  G. Paone,et al.  Blood conservation in coronary artery surgery. , 1994, Surgery.

[12]  W. van Oeveren,et al.  Systemic blood activation during and after autotransfusion. , 1994, The Annals of thoracic surgery.

[13]  J. Gold,et al.  Erythropoietin in Cardiac Surgery , 1993, Journal of cardiac surgery.

[14]  V. Ferraris,et al.  Comparison of blood reinfusion techniques used during coronary artery bypass grafting. , 1993, The Annals of thoracic surgery.

[15]  G. Gravlee.  Autologous platelet-rich plasma in cardiac surgery: aesthetics versus virtue. , 1993, Journal of cardiothoracic and vascular anesthesia.

[16]  P. Mongan,et al.  The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. , 1992, Anesthesiology.

[17]  W. Scott,et al.  Efficacy, complications, and cost of a comprehensive blood conservation program for cardiac operations. , 1992, Journal of Thoracic and Cardiovascular Surgery.

[18]  J. Thornby,et al.  Benefit from combining blood conservation measures in cardiac operations. , 1991, The Annals of thoracic surgery.

[19]  W. Scott,et al.  Blood conservation in cardiac surgery. , 1990, The Annals of thoracic surgery.

[20]  F. Loop,et al.  Determinants of blood utilization during myocardial revascularization. , 1985, The Annals of thoracic surgery.

[21]  N. Mills,et al.  Fresh Autologous Blood Transfusions with Extracorporeal Circulation , 1973, Annals of surgery.

[22]  K. Krieger,et al.  Assessment and Control of Postoperative Bleeding , 1998 .

[23]  D. Gibson,et al.  COMPARISON OF CHANGES IN LEFT-VENTRICULAR FUNCTION IMMEDIATELY AFTER AORTIC-VALVE REPLACEMENT USING CRYSTALLOID, COLD OR WARM BLOOD CARDIOPLEGIA , 1994 .

[24]  S. Neubauer,et al.  CHRONIC BETA-BLOCKER TREATMENT FOLLOWING MYOCARDIAL-INFARCTION REVERSES BIOCHEMICAL REMODELING OF NONINFARCTED TISSUE , 1993 .

[25]  N. Laird,et al.  Perioperative red blood cell transfusion , 1988 .